Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
XBIO
XBIO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
XBIO News
Upstream Bio Shares Surge Nearly 20% on Positive Trial Results
4d ago
stocktwits
What’s Driving the Rise of Pharmaceutical Stocks XBIO, UPC, XTLB, and ACXP Today?
Oct 08 2025
TipRanks
Xenetic Biosciences (XBIO) Reports Q2 Loss, Misses Revenue Estimates
Aug 12 2025
NASDAQ.COM
Xenetic presents preclinical data on DNase I with CAR T cells in murine model
Mar 13 2025
Business Insider
HC Wainwright & Co. Reiterates Neutral on Xenetic Biosciences
Nov 22 2024
Benzinga
Progyny (PGNY) Tops Q3 Earnings Estimates
Nov 12 2024
NASDAQ.COM
XBIO Stock Earnings: Xenetic Biosciences Meets EPS, Beats Revenue for Q2 2024
Aug 14 2024
Business Insider
Xenetic Biosciences, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update
Aug 14 2024
accesswire
Xenetic Biosciences (XBIO) Reports Q2 Loss, Tops Revenue Estimates
Aug 13 2024
NASDAQ.COM
ElectroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates
Aug 07 2024
NASDAQ.COM
Xenetic Biosciences appoints James Parslow as interim CEO
May 22 2024
SeekingAlpha
Xenetic Biosciences Reports Q1 Loss, Misses Revenue Estimates
May 10 2024
Benzinga
XBIO Stock Earnings: Xenetic Biosciences Beats EPS, Misses Revenue for Q1 2024
May 10 2024
Business Insider
Xenetic Biosciences (XBIO) Reports Q1 Loss, Misses Revenue Estimates
May 10 2024
NASDAQ.COM
XBIO Stock Earnings: Xenetic Biosciences Beats EPS, Misses Revenue for Q4 2023
Mar 22 2024
Business Insider
Show More News
